Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 19;10(10):727.
doi: 10.3390/jof10100727.

Recent Advances in Diagnostic Approaches for Mucormycosis

Affiliations
Review

Recent Advances in Diagnostic Approaches for Mucormycosis

Jawad Safiia et al. J Fungi (Basel). .

Abstract

Mucormycosis, an invasive fungal infection caused by members of the order Mucorales, often progresses fulminantly if not recognized in a timely manner. This comprehensive review discusses the latest developments in diagnostic approaches for mucormycosis, from traditional histopathology and culture-based methods to advanced and emerging techniques such as molecular assays, imaging, serology, and metabolomics. We discuss challenges in the diagnosis of mucormycosis and emphasize the importance of rapid and accurate identification of this life-threatening infection.

Keywords: Mucorales; fungal biomarkers; medical mycology; metabolomics; mucormycosis; volatile organic compounds.

PubMed Disclaimer

Conflict of interest statement

Sophia Koo-research funding: NIH/NIAID R44 AI141264, NIAID R01AI138999, NIAID R01AI175040, NCATS U01 TR004072; research funding from Merck Sharp & Dohme Corp, Scynexis, Inc, GlaxoSmithKline, Ansun BioPharma, Locus Biosciences. Consulting fees: Generate Biomedicines, Vertex Pharmaceuticals. Patent pending: Volatile metabolite profiles for the diagnosis and treatment of Mucorales fungi, US Patent 1096000.

Figures

Figure 1
Figure 1
Reverse halo sign (red arrow) in (A) axial and (B) coronal chest CT images from a patient with pulmonary mucormycosis caused by Rhizopus arrhizus.
Figure 2
Figure 2
Hematoxylin–eosin (H&E) stained slide demonstrating the broad, ribbon-like pauci-septate, 90-degree angle branching hyphae of Rhizopus in a patient with disseminated infection in the brain tissue. Image courtesy of Dr. Isaac Solomon.
Figure 3
Figure 3
Grocott–Gömöri’s methenamine silver (GMS) stained slide showing more narrow, septate, acute-angle branching hyphae of Aspergillus fumigatus in a patient with invasive aspergillosis.

References

    1. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudsen T.A., Sarkisova T.A., Schaufele R.L., Sein M., Sein T., Chiou C.C., Chu J.H., et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin. Infect. Dis. 2005;41:634–653. doi: 10.1086/432579. - DOI - PubMed
    1. Jeong W., Keighley C., Wolfe R., Lee W.L., Slavin M.A., Kong D.C.M., Chen S.C.-A. The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin. Microbiol. Infect. 2019;25:26–34. doi: 10.1016/j.cmi.2018.07.011. - DOI - PubMed
    1. Slavin M., van Hal S., Sorrell T.C., Lee A., Marriott D.J., Daveson K., Kennedy K., Hajkowicz K., Halliday C., Athan E., et al. Invasive infections due to filamentous fungi other than Aspergillus: Epidemiology and determinants of mortality. Clin. Microbiol. Infect. 2015;21:e1–e10. doi: 10.1016/j.cmi.2014.12.021. - DOI - PubMed
    1. Lanternier F., Dannaoui E., Morizot G., Elie C., Garcia-Hermoso D., Huerre M., Bitar D., Dromer F., Lortholary O. A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005–2007) Clin. Infect. Dis. 2012;54:S35–S43. doi: 10.1093/cid/cir880. - DOI - PubMed
    1. Kontoyiannis D.P., Yang H., Song J., Kelkar S.S., Yang X., Azie N., Harrington R., Fan A., Lee E., Spalding J.R. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: A retrospective study. BMC Infect. Dis. 2016;16:730. doi: 10.1186/s12879-016-2023-z. - DOI - PMC - PubMed

LinkOut - more resources